Matthew Thompson
CIK 1740988 · Chief Medical Officer · last filed 2024-06-28
Matthew Thompson is a Chief Medical Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for VVOS, was dated Jun 28, 2024.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VVOS | Director | — | $0.57 | — | $0 | 3 | 2024-06-28 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Chief Medical Officer | 78,966 | — | — | $0 | 8 | 2020-02-04 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-28 | VVOS | Grant (A) | — | $0 | EDGAR |
| 2022-12-28 | VVOS | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | VVOS | Grant (A) | — | $0 | EDGAR |
| 2020-08-14 | — | Sell (S) | −21,888 | -$1.9K | |
| 2020-08-07 | — | Disp (D) | +27,016 | -$239 | |
| 2020-02-04 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | +1,131 | -$783 | EDGAR |
| 2020-01-02 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | +41,733 | -$8.9K | EDGAR |
| 2019-10-01 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | — | $0 | EDGAR |
| 2019-08-06 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | +30,433 | $0 | EDGAR |
| 2019-05-10 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Mixed | +829 | -$2.7K | EDGAR |